SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Martin Luther Synthetic CCD

PatientMartin Luther
Date of birth1982-11-19
IdentifiersMRN HR-RE004-SYN; SSN (made up) 000-04-3892
Document date2026-11-01
AuthorOttilie Brandt-Mensah, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for attacks of vertigo with left-ear tinnitus and muffled hearing, and low mood: history, neurological and ear examination, blood and urine tests, depression and safety screening, and an otology referral. Concerns: He is frightened of another attack, especially while preaching or teaching, and of losing the hearing in his left ear; He has felt low and abandoned for weeks and wonders whether the attacks are a spiritual trial rather than an illness; He remembers the pain of the stone last year and wants to avoid another. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Meclizine 25 mg tablet, one by mouth up to every 8 hours during a severe vertigo attack only, for no more than 3 days at a timeevery 8 hours as needed during a severe attack, at most 3 days at a timeOral route2026-07-28activeS
Naproxen 500 mg tablet, one by mouth twice daily with food for up to 7 days for stone paintwice daily with food for up to 7 daysOral route2026-08-25 to 2026-09-01completedS
Tamsulosin 0.4 mg capsule, one by mouth daily for up to 4 weeks or until the stone passesonce daily until the stone passesOral route2026-08-25 to 2026-09-03completedS
Hydrochlorothiazide 25 mg tablet, one by mouth each morningonce daily in the morningOral route2026-08-11activeS
Sertraline 25 mg tablet, one by mouth each morning for one weekonce daily in the morningOral route2026-08-11 to 2026-08-18completedS
Sertraline 50 mg tablet, one by mouth each morningonce daily in the morningOral route2026-08-18activeS

Procedures

ProcedureDatesStatusEvidence
Low-dose non-contrast CT of the kidneys, ureters and bladder2026-08-25 to 2026-08-25completedS
Advance care planning conversation, about 16 minutes2026-09-08 to 2026-09-08completedS
Pure-tone and speech audiometry with tympanometry2026-08-11 to 2026-08-11completedS
MRI of the internal auditory canals with gadolinium2026-09-22 to 2026-09-22completedS
Renal and bladder ultrasound2026-09-22 to 2026-09-22completedS
Repeat pure-tone and speech audiometry2026-10-27 to 2026-10-27completedS

Immunizations

DateVaccineStatusEvidence
2026-09-08Tdap vaccinecompletedS
2026-09-08Influenza vaccine, inactivated, trivalent, preservative-freecompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
his twentiesRecurrent spiritual crises with anxiety, fear and a deeply troubled conscience since his years as a monk in his twenties, which he called AnfechtungenD (CLM-0003)
the past four yearsHeadaches with noises in the ears since his late twenties, and headaches with faint spells and dizziness reported by his physician for about four yearsD (CLM-0007)
May 1521 (Julian)Painful constipation with sleeplessness in his late thirtiesD (CLM-0006)
last yearA urinary stone passed last year after excruciating pain, preceded by headache, heaviness in the head, dizziness and nauseaD (CLM-0008)
earlier this yearSevere low mood earlier this year during bitter disputes in his workD (CLM-0011)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He is frightened of another attack, especially while preaching or teaching, and of losing the hearing in his left earactiveS
He has felt low and abandoned for weeks and wonders whether the attacks are a spiritual trial rather than an illnessactiveS
He remembers the pain of the stone last year and wants to avoid anotheractiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 15.1 on 2026-07-28; Leukocytes [#/volume] in Blood by Automated count 9.8 on 2026-08-25; Platelets [#/volume] in Blood by Automated count 238 on 2026-07-28; Sodium [Moles/volume] in Serum or Plasma 137 on 2026-10-27; Potassium [Moles/volume] in Serum or Plasma 3.8 on 2026-10-27; Carbon dioxide, total [Moles/volume] in Serum or Plasma 26 on 2026-07-28; Urea nitrogen [Mass/volume] in Serum or Plasma 15 on 2026-07-28; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 2026-10-27; Glucose [Mass/volume] in Serum or Plasma 92 on 2026-09-22; Calcium [Mass/volume] in Serum or Plasma 9.9 on 2026-10-27; Urate [Mass/volume] in Serum or Plasma 7.4 on 2026-09-22; Thyrotropin [Units/volume] in Serum or Plasma 1.8 on 2026-07-28; Erythrocytes [#/area] in Urine sediment by Microscopy high power field 30 on 2026-08-25; pH of Urine by Test strip 5.5 on 2026-08-25; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 98 on 2026-10-27; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 on 2026-10-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 9 on 2026-07-28; Cholesterol [Mass/volume] in Serum or Plasma 214 on 2026-09-08; Triglyceride [Mass/volume] in Serum or Plasma 168 on 2026-09-08; Cholesterol in HDL [Mass/volume] in Serum or Plasma 41 on 2026-09-08; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 139 on 2026-09-08; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 2026-09-08; Volume of 24 hour Urine 1.6 on 2026-10-27; Calcium [Mass/time] in 24 hour Urine 190 on 2026-10-27; Oxalate [Mass/time] in 24 hour Urine 38 on 2026-10-27; Citrate [Mass/time] in 24 hour Urine 410 on 2026-10-27; Sodium [Moles/time] in 24 hour Urine 140 on 2026-10-27; Urate [Mass/time] in 24 hour Urine 680 on 2026-10-27; Creatinine [Mass/time] in 24 hour Urine 1750 on 2026-10-27 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent attacks of spinning vertigo for about three months, the worst twelve days ago, lasting hours, with roaring tinnitus, fullness and muffled hearing in the left ear and nausea, the tinnitus persisting between attacks; with low mood, poor sleep and loss of interest; cause not established at intake: an inner-ear disorder suspected, with vestibular migraine, vestibular schwannoma and posterior circulation stroke to be excluded and depression to be assessed; otology consultation requestedresolvedconfirmed R42S — Synthetic presenting problem anchored to his documented attacks of April and July 1527; superseded by the diagnoses at the second visit.
Ménière disease of the left ear, definite (AAO-HNS 2020 and Bárány Society criteria), with low-frequency sensorineural hearing loss and persistent tinnitus in the left ear; vestibular migraine considered and judged unlikely as the main cause; vestibular schwannoma excluded by MRIactiveconfirmed H81.02S — Synthetic modern diagnosis made at the otology consultation, linked to his documented attacks and to the retrospective diagnosis of Ménière disease (R).
Major depressive disorder, recurrent, moderate (DSM-5-TR), with low mood, poor sleep, loss of interest, guilt and fatigue for about two months, after earlier periods of spiritual crisis and low mood; no suicidal ideationactiveconfirmed F33.1S — Synthetic modern diagnosis linked to his documented Anfechtungen and low periods; not a claim that he was so diagnosed; the retrospective psychiatric readings are disputed (R).
Urinary stone disease: one stone passed spontaneously last year after severe pain; stone type and metabolic risk not yet known at intakeactiveconfirmed Z87.442S — Synthetic modern problem anchored to his documented first stone in 1526.
Right distal ureteral stone, 5 mm, at the ureterovesical junction, with mild right hydronephrosis and renal colic; no infection; kidney function normal; managed with naproxen and tamsulosin; passed nine days later; resolvedresolvedconfirmed N20.1S — Synthetic acute problem anchored to his documented recurrent stones; this episode is not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-28Hemoglobin [Mass/volume] in Blood15.1g/dL13.5-17.5 g/dLNormalS
2026-07-28Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2026-07-28Platelets [#/volume] in Blood by Automated count23810*3/uL150-400 10*3/uLNormalS
2026-07-28Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-07-28Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-07-28Carbon dioxide, total [Moles/volume] in Serum or Plasma26mmol/L22-29 mmol/LNormalS
2026-07-28Urea nitrogen [Mass/volume] in Serum or Plasma15mg/dL7-20 mg/dLNormalS
2026-07-28Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-07-28Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-07-28Calcium [Mass/volume] in Serum or Plasma9.7mg/dL8.6-10.3 mg/dLNormalS
2026-07-28Urate [Mass/volume] in Serum or Plasma6.9mg/dL3.7-8 mg/dLNormalS
2026-07-28Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.45-4.5 mIU/LNormalS
2026-07-28Erythrocytes [#/area] in Urine sediment by Microscopy high power field1/[HPF]0 to 2 per high-power fieldNormalS
2026-07-28pH of Urine by Test strip5.5[pH]5-8 [pH]NormalS
2026-07-28Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M94mL/min/{1.73_m2}60 or moreNormalS
2026-07-28Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]15{score}S
2026-07-28Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S
2026-08-25Leukocytes [#/volume] in Blood by Automated count9.810*3/uL4-11 10*3/uLNormalS
2026-08-25Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-08-25Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.1 mmol/LNormalS
2026-08-25Creatinine [Mass/volume] in Serum or Plasma1.12mg/dL0.74-1.35 mg/dLNormalS
2026-08-25Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M84mL/min/{1.73_m2}60 or moreNormalS
2026-08-25Glucose [Mass/volume] in Serum or Plasma108mg/dL70-99 mg/dLHighS
2026-08-25Erythrocytes [#/area] in Urine sediment by Microscopy high power field30/[HPF]0 to 2 per high-power fieldHighS
2026-08-25pH of Urine by Test strip5.5[pH]5-8 [pH]NormalS
2026-09-08Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]12{score}S
2026-09-08Cholesterol [Mass/volume] in Serum or Plasma214mg/dLBelow 200HighS
2026-09-08Triglyceride [Mass/volume] in Serum or Plasma168mg/dLBelow 150HighS
2026-09-08Cholesterol in HDL [Mass/volume] in Serum or Plasma41mg/dL40 or moreNormalS
2026-09-08Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation139mg/dLBelow 130HighS
2026-09-08Hemoglobin A1c/Hemoglobin.total in Blood5.6%Below 5.7NormalS
2026-08-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
2026-09-22Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-09-22Potassium [Moles/volume] in Serum or Plasma3.7mmol/L3.5-5.1 mmol/LNormalS
2026-09-22Creatinine [Mass/volume] in Serum or Plasma1mg/dL0.74-1.35 mg/dLNormalS
2026-09-22Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-09-22Calcium [Mass/volume] in Serum or Plasma10mg/dL8.6-10.3 mg/dLNormalS
2026-09-22Urate [Mass/volume] in Serum or Plasma7.4mg/dL3.7-8 mg/dLNormalS
2026-09-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M96mL/min/{1.73_m2}60 or moreNormalS
2026-09-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]10{score}S
2026-10-27Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-10-27Potassium [Moles/volume] in Serum or Plasma3.8mmol/L3.5-5.1 mmol/LNormalS
2026-10-27Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-10-27Calcium [Mass/volume] in Serum or Plasma9.9mg/dL8.6-10.3 mg/dLNormalS
2026-10-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M98mL/min/{1.73_m2}60 or moreNormalS
2026-10-27Volume of 24 hour Urine1.6L/(24.h)2.5 or more for stone preventionLowS
2026-10-27Calcium [Mass/time] in 24 hour Urine190mg/(24.h)Below 250 in menNormalS
2026-10-27Oxalate [Mass/time] in 24 hour Urine38mg/(24.h)Below 40NormalS
2026-10-27Citrate [Mass/time] in 24 hour Urine410mg/(24.h)450 or moreLowS
2026-10-27Sodium [Moles/time] in 24 hour Urine140mmol/(24.h)Below 100 for stone preventionHighS
2026-10-27Urate [Mass/time] in 24 hour Urine680mg/(24.h)Below 800 in menNormalS
2026-10-27Creatinine [Mass/time] in 24 hour Urine1750mg/(24.h)1,000 to 2,000 in men; checks completenessNormalS
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-07-28Body height175cmS
2026-07-28Body weight86kgS
2026-07-28Body mass index (BMI) [Ratio]28.1kg/m2S
2026-07-28Systolic blood pressure128mm[Hg]S
2026-07-28Diastolic blood pressure82mm[Hg]S
2026-07-28Heart rate76/minS
2026-07-28Respiratory rate14/minS
2026-07-28Body temperature36.7CelS
2026-07-28Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-11Body height175cmS
2026-08-11Body weight86.2kgS
2026-08-11Body mass index (BMI) [Ratio]28.1kg/m2S
2026-08-11Systolic blood pressure126mm[Hg]S
2026-08-11Diastolic blood pressure80mm[Hg]S
2026-08-11Heart rate74/minS
2026-08-11Respiratory rate14/minS
2026-08-11Body temperature36.6CelS
2026-08-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-22Body height175cmS
2026-09-22Body weight85.1kgS
2026-09-22Body mass index (BMI) [Ratio]27.8kg/m2S
2026-09-22Systolic blood pressure122mm[Hg]S
2026-09-22Diastolic blood pressure78mm[Hg]S
2026-09-22Heart rate72/minS
2026-09-22Respiratory rate14/minS
2026-09-22Body temperature36.7CelS
2026-09-22Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-27Body height175cmS
2026-10-27Body weight84.4kgS
2026-10-27Body mass index (BMI) [Ratio]27.6kg/m2S
2026-10-27Systolic blood pressure120mm[Hg]S
2026-10-27Diastolic blood pressure78mm[Hg]S
2026-10-27Heart rate70/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-25Body height175cmS
2026-08-25Body weight85.8kgS
2026-08-25Body mass index (BMI) [Ratio]28kg/m2S
2026-08-25Systolic blood pressure142mm[Hg]S
2026-08-25Diastolic blood pressure88mm[Hg]S
2026-08-25Heart rate96/minS
2026-08-25Respiratory rate18/minS
2026-08-25Body temperature36.9CelS
2026-08-25Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-08Body height175cmS
2026-09-08Body weight85.4kgS
2026-09-08Body mass index (BMI) [Ratio]27.9kg/m2S
2026-09-08Systolic blood pressure124mm[Hg]S
2026-09-08Diastolic blood pressure80mm[Hg]S
2026-09-08Heart rate72/minS
2026-09-08Respiratory rate14/minS
2026-09-08Body temperature36.6CelS
2026-09-08Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-07-28New patient visit for attacks of vertigo with left-ear tinnitus and muffled hearing, and low mood: history, neurological and ear examination, blood and urine tests, depression and safety screening, and an otology referralfinishedS
2026-08-11Two-week review and otology consultation with audiometry; diagnoses of Ménière disease and recurrent depressionfinishedS
2026-09-22Six-week review: attacks, MRI result, thiazide and sertraline safety, mood, and the passed stonefinishedS
2026-10-27Thirteen-week review: attacks, repeat audiogram, mood, and the 24-hour urine for stone preventionfinishedS
2026-08-25Same-day sick visit for right flank painfinishedS
2026-09-08Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Otology (neurotology) consultation in two weeks, with audiometry, to confirm the cause of the attacks and plan treatmentcompletedGL-AAO-MD-2020S
Diagnostic work-up at intake: ear and neurological examination, positional testing, blood count, kidney function and electrolytes, calcium, uric acid, TSH and urinalysis; a symptom diary of each attack (start, duration, hearing, tinnitus, ear fullness, headache, light sensitivity); formal audiometry at the otology visitcompletedGL-AAO-MD-2020, GL-BARANY-MD-2015, GL-VM-2022S
Meclizine only for severe attacks, for no more than three days at a time; sit or lie down at the first warning; no driving, ladders or swimming alone while attacks are activecompletedGL-AAO-MD-2020S
Depression: PHQ-9 at every visit, a structured diagnostic interview at the next visit, and a safety plan with the 988 Suicide & Crisis Lifeline and the clinic numbercompletedGL-CMID-2026, GL-APA-DEP-2019, GL-SUICIDE-2024S
Stone history: drink enough water to pass at least 2.5 liters of urine a day; serum calcium and uric acid at intake; stone analysis and metabolic testing if another stone occurscompletedGL-AUA-STONE-2014S
Ménière disease: education; sodium 1,500 to 2,300 mg a day; caffeine and alcohol limited; hydrochlorothiazide 25 mg daily as maintenance, with sodium and potassium checked at the next visit; no betahistine; MRI of the internal auditory canals with gadolinium; repeat audiogram at about three months; intratympanic steroid held in reserve if disabling attacks continue after three monthscompletedGL-AAO-MD-2020, GL-BEMED-2016S
Recurrent depression: weekly cognitive behavioral therapy with behavioral activation, and sertraline 25 mg daily for a week, then 50 mg, by shared decision; sodium checked on sertraline with the thiazidecompletedGL-APA-DEP-2019, GL-CMID-2026S
Right ureteral stone: naproxen for pain, tamsulosin as medical expulsive therapy for up to four weeks, urine strained and the stone sent for analysis, and renal ultrasound after passagecompletedGL-AUA-SURG-STONE-2016, GL-AUA-STONE-2014S
Vestibular rehabilitation for unsteadiness between attacks: a home program taught by a vestibular physical therapistcompletedGL-AAO-MD-2020S
Stone prevention from the 24-hour urine: fluids to at least 2.5 liters of urine a day, sodium restriction with a dietitian, normal dietary calcium, citrus fruit for citrate, thiazide continued, and a repeat 24-hour urine in about six monthscompletedGL-AUA-STONE-2014S

Goals

GoalTargetStatusOutcomeProvenance
Fewer and milder vertigo attacks: no more than one disabling attack a month by three months, and able to preach without fear of an attack2026-10-27completedOne attack between the second and six-week visits and none in the five weeks before the thirteen-week visit; preaching againS
Depression response (PHQ-9 down by at least 50 percent) by three months2026-10-27completedPHQ-9 6 at thirteen weeks, down 60 percent from 15S
Sodium intake below 2,300 mg a day2027-01-31active24-hour urine sodium 140 mmol (about 3,200 mg) at thirteen weeks: improved but above targetS
Urine volume of at least 2.5 liters a day2027-01-31active24-hour urine volume 1.6 liters at thirteen weeksS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-07-28: current ideation absent, intent absent, plan absent. No suicidal ideation, intent, plan or past attempts; during the worst attack he believed he would die but did not wish to. Outpatient care with a safety plan, the 988 Suicide & Crisis Lifeline and the clinic number, and review at every visit [S]